Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Report Available: Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-27 08:04:01 - Recently published research from MarketLine, "Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report", is now available at Fast Market Research

Idenix Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Idenix Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Idenix Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Idenix Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Idenix Pharmaceuticals, Inc.
* Intelligence on Idenix Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Idenix Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757230_idenix_pharmaceuticals_inc_swot_strat ..

Highlights:

Idenix Pharmaceuticals, Inc. (Idenix or 'the company'), a development-stage biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of human viral diseases. The company's current focus is on the treatment of hepatitis C virus (HCV) infections. Idenix operates in the US and France. It is headquartered in Cambridge, Massachusetts, and employed 107 people as of December 31, 2012. The company recorded revenues of $69.7 million during the financial year ended December 2012 (FY2012), as compared to revenues of $7 million in FY2011. The operating loss of the company was $35.4 million in FY2012, as compared to an operating loss of $53.4 million in FY2011. The net loss was $32.4 million in FY2012, as compared to a net loss of $52 million in FY2011.

Reasons to Purchase:

* Gain understanding of Idenix Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Idenix Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Idenix Pharmaceuticals, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Idenix Pharmaceuticals, Inc.: Company Overview
Idenix Pharmaceuticals, Inc.: Overview and Key Facts
Idenix Pharmaceuticals, Inc.: Overview
Idenix Pharmaceuticals, Inc.: Key Facts
Idenix Pharmaceuticals, Inc.: Key Employees
Idenix Pharmaceuticals, Inc.: Key Employee Biographies
Idenix Pharmaceuticals, Inc.: Major Products and Services
Idenix Pharmaceuticals, Inc.: Company History
Idenix Pharmaceuticals, Inc.: Management Statement
Idenix Pharmaceuticals, Inc.: Locations and Subsidiaries
Idenix Pharmaceuticals, Inc.: Key Competitors
Idenix Pharmaceuticals, Inc.: Company Analysis
Idenix Pharmaceuticals, Inc.: Business Description
Idenix Pharmaceuticals, Inc.: SWOT Analysis
Idenix Pharmaceuticals, Inc.: SWOT Overview
Idenix Pharmaceuticals, Inc.: Strengths
Idenix Pharmaceuticals, Inc.: Weaknesses
Idenix Pharmaceuticals, Inc.: Opportunities
Idenix Pharmaceuticals, Inc.: Threats
Idenix Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Idenix Pharmaceuticals, Inc.: Financial Deals Overview
Idenix Pharmaceuticals, Inc.: Targets and Partners
Idenix Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Idenix Pharmaceuticals, Inc.: Advisors
Idenix Pharmaceuticals, Inc.: Top Legal Advisors
Idenix Pharmaceuticals, Inc.: Top Financial Advisors
Idenix Pharmaceuticals, Inc.: Capital Raising
Idenix Pharmaceuticals, Inc.: Partnership
Idenix Pharmaceuticals, Inc.: Recent Developments
Idenix Pharmaceuticals, Inc.: News and Events Summary
Idenix Pharmaceuticals, Inc.: Corporate Governance
Idenix Pharmaceuticals, Inc.: Financial Performance
Idenix Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Idenix Pharmaceuticals, Inc.: Key Facts
Table 2: Idenix Pharmaceuticals, Inc.: Key Employees
Table 4: Idenix Pharmaceuticals, Inc.: Key Competitors
Table 5: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Idenix Pharmaceuticals, Inc.: Targets and Partners
Table 7: Idenix Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 8: Idenix Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: Idenix Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 11: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 12: Idenix Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 13: Idenix Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 14: Idenix Pharmaceuticals, Inc.: News and Events Summary
Table 15: Idenix Pharmaceuticals, Inc.: Corporate Governance
Table 16: Idenix Pharmaceuticals, Inc.: Financial Performance
Table 17: Idenix Pharmaceuticals, Inc.: Research & Development

List of Figures

Figure 1: Idenix Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 2: Idenix Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 3: Idenix Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757230&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com